Exosens (CHIX:EXENSP) Other Long-Term Liabilities: €298.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:EXENSP Exosens SA CHIX:EXENSP
42 GF Score
Price €63.70
! 7 Warning Signs
View Full Analysis

What is Exosens Other Long-Term Liabilities?

Exosens CHIX:EXENSP 42 Other Long-Term Liabilities is €298.1 Mil as of Dec. 2025. GuruFocus rates CHIX:EXENSP with a GF Score™ of 42/100. The stock has 7 warning signs investors should review.

Exosens's other long-term liabilities for the quarter that ended in Dec. 2025 was €298.1 Mil.

Exosens's quarterly other long-term liabilities increased from Dec. 2024 (€34.9 Mil) to Jun. 2025 (€42.5 Mil) and increased from Jun. 2025 (€42.5 Mil) to Dec. 2025 (€298.1 Mil).

Exosens's annual other long-term liabilities increased from Dec. 2023 (€30.7 Mil) to Dec. 2024 (€34.9 Mil) and increased from Dec. 2024 (€34.9 Mil) to Dec. 2025 (€298.1 Mil).

Exosens Other Long-Term Liabilities Related Terms

Exosens Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Exosens's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exosens Other Long-Term Liabilities Chart

Exosens Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial 30.93 24.09 30.72 34.88 298.10

Exosens Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only 30.72 28.72 34.88 42.52 298.10
CHIX:EXENSP
42GF Score
Exosens SA CHIX:EXENSP
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Exosens Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of €298.1 Mil mean?
Exosens (CHIX:EXENSP) has a Other Long-Term Liabilities of €298.1 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Exosens and its competitors.
Is Exosens' Other Long-Term Liabilities too high?
Exosens' current Other Long-Term Liabilities is €298.1 Mil. Overall, Exosens has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Exosens' Other Long-Term Liabilities compare to VRT and BE?
Exosens' Other Long-Term Liabilities of €298.1 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for an Industrial Products company?
A good Other Long-Term Liabilities depends on the Industrial Products industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Exosens and its competitors. Exosens's current Other Long-Term Liabilities is €298.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exosens stock overvalued right now?
Exosens (CHIX:EXENSP) has a current Other Long-Term Liabilities of €298.1 Mil. The current Other Long-Term Liabilities is €298.1 Mil. Exosens' overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Exosens (CHIX:EXENSP), the current Other Long-Term Liabilities is €298.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exosens Business Description

Address 18 Avenue de Pythagore, Domaine de Pelus, Axis Business Park Bat 5E, Merignac, FRA, 33700
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company's activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
42GF Score

Get the complete analysis for CHIX:EXENSP

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.70
Price